The FDA declined to approve MDMA-assisted therapy, commonly known as ecstasy, as a treatment for PTSD. FDA rejects MDMA-assisted therapy for PTSD in a setback for psychedelic medicine.

FDA rejects psychedelic MDMA as treatment for PTSD, calling for additional study Drugmaker Lykos Therapeutics said the FDA notified the company that its drug “could not be approved based on data ...

FDA rejects MDMA therapy for treatment of PTSD. ... The FDA was considering an application for a treatment manufactured by the California-based biotech Lykos Therapeutics that involves intense ...

There are only two FDA-approved treatments for PTSD. MDMA would be the first to come on the market in decades. Though classified as a Schedule I drug, the FDA granted MDMA "breakthrough therapy ...

MDMA studies suggested the psychedelic was effective, but strong opposition from a FDA advisory panel doomed Lykos Therapeutics' application. ... FDA rejects MDMA as a psychedelic treatment for PTSD.

WASHINGTON (AP) — Federal health regulators on Friday declined to approve the psychedelic drug MDMA as a therapy for PTSD, a major setback for groups seeking a breakthrough decision in favor of ...

FDA rejects psychedelic MDMA as treatment for PTSD, calling for additional study Drugmaker Lykos Therapeutics said the FDA notified the company that its drug “could not be approved based on data ...

FDA rejects psychedelic MDMA as treatment for PTSD. By Matthew Perrone Aug 9, 2024. Federal health officials have declined to approve the psychedelic drug MDMA as a therapy for PTSD.